Compare ImmunityBio Inc. Common Stock (IBRX) vs Regions Financial Corporation Common Stock (RF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs Regions Financial Corporation Common Stock — how do they compare? ImmunityBio Inc. Common Stock trades at $10.69 (market cap $10.51B), while Regions Financial Corporation Common Stock trades at $26.97 (market cap $23.06B). The key difference: Regions Financial Corporation Common Stock is far larger — about 2.2× ImmunityBio Inc. Common Stock's market cap, and Regions Financial Corporation Common Stock pays a 4.05% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 1 Days and Regions Financial Corporation Common Stock for 1 Days on average.
| IBRX | RF | |
|---|---|---|
Market Cap | $10.51B | $23.06B |
Volume | 10,445,785 | 13,190,101 |
Sector | Health | Financials |
52-Week High | $11.55 | $32.40 |
52-Week Low | $1.98 | $23.35 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $10.97B | $20.80B |
Dividend Yield | — | 4.05% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About Regions Financial Corporation Common Stock
Regions Financial is a financial holding company that operates through Regions Bank. It provides consumer, commercial, mortgage, wealth-management, and investment services across the South, Midwest, and Texas.
Read more on RF →
